BackgroundPreoperative assessment of epidermal growth factor receptor (EGFR) status, response to EGFR‐tyrosine kinase inhibitors (TKI) and development of T790M mutation in non‐small cell lung carcinoma (NSCLC) patients with brain metastases (BM) is important for clinical decision‐making, while previous studies were only based on the whole BM.PurposeTo investigate values of brain‐to‐tumor interface (BTI) for determining the EGFR mutation, response to EGFR‐TKI and T790M mutation.Study TypeRetrospective.PopulationTwo hundred thirty patients from Hospital 1 (primary cohort) and 80 patients from Hospital 2 (external validation cohort) with BM and histological diagnosis of primary NSCLC, and with known EGFR status (biopsy) and T790M mutation status (gene sequencing).Field Strength/SequenceContrast‐enhanced T1‐weighted (T1CE) and T2‐weighted (T2W) fast spin echo sequences at 3.0T MRI.AssessmentTreatment response to EGFR‐TKI therapy was determined by the Response Evaluation Criteria in Solid Tumors. Radiomics features were extracted from the 4 mm thickness BTI and selected by least shrinkage and selection operator regression. The selected BTI features and volume of peritumoral edema (VPE) were combined to construct models using logistic regression.Statistical TestsThe performance of each radiomics model was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC).ResultsA total of 7, 3, and 3 features were strongly associated with the EGFR mutation status, response to EGFR‐TKI and T790M mutation status, respectively. The developed models combining BTI features and VPE can improve the performance than those based on BTI features alone, generating AUCs of 0.814, 0.730, and 0.774 for determining the EGFR mutation, response to EGFR‐TKI and T790M mutation, respectively, in the external validation cohort.Data ConclusionBTI features and VPE were associated with the EGFR mutation status, response to EGFR‐TKI and T790M mutation status in NSCLC patients with BM.Evidence Level: 3Technical Efficacy: Stage 2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.